In silico targeting of interleukin-6 by natural compounds
Rheumatoid arthritis an autoimmune disorder affecting many tissues and organs, is a challenging prospect in terms of treatment. Our work is looking into finding lead compound of natural origin against IL-6, an important cyto-kine having a profound role in pathogenesis of rheumatoid arthritis . For t...
Main Authors: | Wei Zhou, Jun-Feng Cai, Feng Yuan, Min Ma, Feng Yin |
---|---|
Format: | Article |
Language: | English |
Published: |
Bangladesh Pharmacological Society
2014-08-01
|
Series: | Bangladesh Journal of Pharmacology |
Subjects: | |
Online Access: | https://www.banglajol.info/index.php/BJP/article/view/19065 |
Similar Items
-
Interleukin-6 in Rheumatoid Arthritis
by: Franco Pandolfi, et al.
Published: (2020-07-01) -
INTERLEUKIN-6 (IL-6) LEVEL AS AN INDIKATOR OF PROGRESIVITY RHEUMATOID ARTHRITIS (RA) DISEASE
by: Putu Oky Ari Tania, et al.
Published: (2017-06-01) -
Analysis of association of -174G/C interleukin 6 polymorphism and therapeutic response to methotrexate in rheumatoid arthritis
by: Joksimović Anastasija, et al.
Published: (2018-01-01) -
A new interleukin to treat arthrites: anti-interleukin-6
by: Morton Aaron Scheinberg
Published: (2009-03-01) -
Revisiting the 1986 molecular cloning of interleukin 6
by: Toshio eHirano
Published: (2014-09-01)